MedPath

Low Implanted Second Trimester Placenta and Placenta Previa

Completed
Conditions
Placenta Previa
Interventions
Radiation: ultrasound
Registration Number
NCT03431116
Lead Sponsor
Assiut University
Brief Summary

Placenta Previa is defined as a placenta implanted in the lower segment of the uterus, presenting ahead of the leading pole of the fetus (over or near the internal os). The prevalence of placenta previa has been estimated to be approximately 0.5% of all pregnancies, and this increase correlates to the elevated cesarean section rate . In Egypt, the prevalence of placenta previa is around 1.3% in Sohag Governorate and 1.5% in Aswan region according to.

Although various studies have tried to address risk factors associated with Placenta Previa development, the etiology of placenta previa still remains obscure. Several risk actors have been identified as strong contributors to placenta previa development. It is also a significant contributor to severe postpartum hemorrhage.Risk factors include; history of previous cesarean section, advanced maternal age, history of previous abortions, high parity and substance abuse during pregnancy (cigarette smoking), placental size (multiple pregnancy), endometrial damage (previous dilatation and curettage), uterine scars and pathology (previous myomectomy or endometritis), placental pathology (marginal cord insertions and succenturiate lobes), previous placental Previa, and curiously.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
52
Inclusion Criteria
  1. Pregnant women between 18-24 weeks.
  2. Diagnosed to have low implanted placenta by ultrasound
Read More
Exclusion Criteria
  1. Patient refused to follow-up in our setting.
  2. Patient refused to perform Trans-vaginal ultrasound in the second trimester of gestation.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Low implanted placenta groupultrasound-
Primary Outcome Measures
NameTimeMethod
The distance between lower edge of the placenta and internal os by ultrasound (millimeter)12 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Women Health Hospital - Assiut university

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath